Aman Fatima
Podiatrist · Long Island City, NYNPI 1336673565
Payments from drug & device makers
Across 50 payments — averaging $66.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Fortis Surgical, LLC$333
- Stryker$224
- Organogenesis Inc.$100
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$100
- Biowound Solutions, Inc.$77
- plus $470 from 15 others
What the payments were for
- Travel & lodging$91427%
- Food & beverage$1,21737%
- Education$1,20036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 11 | $2,029 |
| Fortis Surgical, LLC | 2 | $333 |
| Stryker | 7 | $224 |
| Organogenesis Inc. | 3 | $100 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $100 |
| Biowound Solutions, Inc. | 4 | $77 |
| Smith+Nephew | 4 | $72 |
| Integra Lifesciences Corporation | 2 | $56 |
| Averitas Pharma Inc. | 2 | $41 |
| Acumed LLC | 1 | $40 |
| GRT US Holding, Inc. | 2 | $35 |
| Abbott | 1 | $32 |
| Ossio Inc | 1 | $30 |
| Reapplix Inc. | 1 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Misonix Inc | 1 | $25 |
| Johnson & Johnson | 1 | $21 |
| AbbVie | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $16 |
| Medtronic | 1 | $14 |
How this compares
$3,332 in reported general payments places this provider in the 80th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diflorasone Diacetate | 21 | $11,042 |
| Naftifine Hcl | 32 | $5,934 |
| Clobetasol Propionate | 41 | $4,597 |
| Fluocinonide | 12 | $1,294 |
| Nitro-BidNitroglycerin | 14 | $1,077 |
| Ketoconazole | 29 | $846 |
| Mupirocin | 42 | $768 |
| Doxycycline Hyclate | 42 | $400 |
| Pregabalin | 11 | $342 |
| Gabapentin | 34 | $322 |
| Cephalexin | 20 | $302 |
| Ammonium Lactate | 14 | $241 |
| Ciprofloxacin Hcl | 23 | $185 |
| Amitriptyline Hcl | 14 | $114 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $94 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Long Island City
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Elvis DanneNew York$35K
- Adam CirlincioneGlen Cove$31K
- Jude ViolanteNiagara Falls$30K
- Ammar Al RubaiayNew Hyde Park$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.